GMABGenmab A/S American Depositary Shares

Genmab A/S American Depositary Shares represents ownership in Genmab A/S, a Denmark-based biotechnology company focused on developing antibody-based therapies. The company’s business centers on human antibody therapeutics for cancer and other serious diseases, with products and product candidates spanning oncology and selected additional therapeutic areas. Its portfolio includes approved and partnered medicines, as well as research programs built around proprietary antibody technologies such as DuoBody and HexaBody. Genmab works across discovery, development, and commercialization, collaborating with pharmaceutical partners to advance biologic treatments through the clinical and regulatory process. The company serves the global biopharmaceutical market and plays a role in supplying innovative immunotherapy and antibody platforms to healthcare providers and patients worldwide.